An open-label single-center investigator-initiated exploratory clinical study in patients with refractory or recurrent solid tumors: ‘R-ISV-FOLactis’ trial
Preprint in Research Square (July 2023)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1
Article in OncoImmunology (June 2023)
Smart Radiotherapy Biomaterials for Image-Guided In Situ Cancer Vaccination
Article in Nanomaterials (June 2023)